2637 studies found for:    Head and Neck Neoplasms [ CONDITION ] OR Mouth Neoplasms [ CONDITION ]
Show Display Options
Rank Status Study
1 Recruiting Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
Conditions: Mouth Neoplasms;   Head and Neck Neoplasms;   Tongue Neoplasms;   Carcinoma, Squamous Cell
Interventions: Drug: Rapamycin;   Procedure: Biopsy;   Procedure: Dynamic CT Perfusion;   Procedure: Positron Emission Tomography;   Procedure: Measurement Serum Cytokines
2 Terminated Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
Conditions: Advanced Squamous Cell Carcinoma of the Head and Neck;   Carcinoma, Squamous Cell;   Neoplasms, Squamous Cell;   Head and Neck Neoplasms;   Mouth Neoplasms;   Head and Neck Cancer
Intervention: Drug: Proxinium
3 Terminated Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
Conditions: Recurrent Squamous Cell Carcinoma of the Head and Neck;   Carcinoma, Squamous Cell;   Neoplasms, Squamous Cell;   Head and Neck Neoplasms;   Mouth Neoplasms;   Head and Neck Cancer
Intervention: Drug: Proxinium
4 Recruiting Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Neoplasms;   Laryngeal Neoplasms;   Mouth Neoplasms;   Pharyngeal Neoplasms
Interventions: Drug: cetuximab (associated with radiotherapy);   Drug: cisplatin (associated to radiotherapy)
5 Withdrawn ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
Conditions: Lip and Oral Cavity Cancer;   Head and Neck Cancer;   Oropharyngeal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: ONYX-015
6 Active, not recruiting F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
Conditions: Mouth Neoplasms;   Oropharyngeal Neoplasms;   Laryngeal Neoplasms;   Head and Neck Neoplasms
Intervention: Drug: F-18 Fluorothymidine
7 Completed Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors
Conditions: Liver Metastasis;   Pelvic Cancer;   Head and Neck Cancer;   Sarcoma;   Rectal Cancer;   Breast Cancer;   Colorectal Cancer;   Mouth Cancer
Interventions: Drug: LS 11(Taporfin Sodium);   Device: Lumaflex Light Delivery Catheter
8 Recruiting Patient Evaluation for Head and Neck Surgery Branch Studies
Conditions: Head and Neck Cancer;   Pharyngeal Cancer;   Oral Cancer;   Carcinoma, Squamous Cell;   Laryngeal Cancer
Intervention:
9 Completed Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer
Conditions: Carcinoma, Squamous;   Head and Neck Cancer;   Oral Cancer;   Laryngeal Cancer;   Pharyngeal Cancer
Interventions: Drug: Bortezomib (Velcade, PS-341);   Drug: Cetuximab;   Drug: Cisplatin;   Procedure: Radiation Therapy
10 Recruiting Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Cancer;   Oral Cavity Cancer;   Oropharyngeal Cancer
Intervention: Drug: Valproic Acid
11 Withdrawn Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema
Conditions: Lymphedema;   Oropharyngeal Cancer;   Head and Neck Cancer;   Oral Cancer
Interventions: Other: Follow -Up Visits;   Other: Full CDT;   Other: Modified CDT Program
12 Completed A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
Conditions: Mouth Cancer;   Lip Cancer;   Throat Cancer;   Lip Neoplasms;   Head and Neck Cancers
Intervention:
13 Completed Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery
Conditions: Oral Cancer;   Head and Neck Cancer;   Free Flap;   Hypotension
Interventions: Drug: Epinephrine;   Drug: Norepinephrine;   Drug: Dobutamine;   Drug: Dopexamine
14 Completed Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer;   Cancer of Parotid;   Malignant Neoplasm of Thyroid;   Melanoma;   Stage IV Head and Neck Cancer
Interventions: Drug: Cisplatin;   Drug: Docetaxel;   Drug: Bevacizumab;   Drug: Erlotinib;   Radiation: Radiotherapy
15 Recruiting Oral Cancer Adjuvant Therapy (OCAT) Trial
Condition: Mouth Neoplasms
Intervention: Procedure: Post-operative chemoradiotherapy / accelerated radiotherapy
16 Completed Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx
Conditions: Lip and Oral Cavity Cancer;   Oropharyngeal Cancer;   Stage 0 Lip and Oral Cavity Cancer;   Stage 0 Oropharyngeal Cancer;   Tongue Cancer
Interventions: Biological: Ad5CMV-p53 gene;   Other: laboratory biomarker analysis
17 Recruiting Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Conditions: Head and Neck Cancer;   Lung Cancer;   Lip Cancer;   Lip Neoplasms;   Head and Neck Cancers
Interventions: Procedure: Tumor biopsy;   Procedure: Phlebotomy
18 Recruiting Polarized Reflectance Spectroscopy for Oral Lesions
Condition: Oral Cancer
Intervention: Device: Polarized Reflectance Spectroscopy System
19 Terminated
Has Results
OraTest in Combination With Visual Examination and Visual Examination Alone
Conditions: Head and Neck Cancer;   Oropharynx Cancer
Interventions: Other: Visual Examination;   Drug: OraTest
20 Recruiting Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
Conditions: Oropharyngeal Cancer;   Oral Cancer;   Lymph Node Metastasis
Intervention: Radiation: Radiation therapy

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years